Table 1.
Participating cohorts | Abbreviation | Country | Baseline | Sample size | No (%) of type 2 diabetes incident cases | Years of follow-up |
---|---|---|---|---|---|---|
Atherosclerosis Risk in Communities Study | ARIC | USA | 1987-1989 | 6690 | 442 (6.6) | 6 |
Bogalusa Heart Study | BHS | USA | 1998-2001 | 790 | 46 (6.6) | 5 |
Cardiovascular Health Study | CHS | USA | 1989-1990 | 2813 | 258 (9.2) | 20 |
Diet, Cancer and Health* | DCH | Denmark | 1993-1997 | 8788 | 3987 (40.1) | 12.5 |
European Prospective Investigation of Cancer-InterAct* | EPIC-InterAct | Europe (10 countries) | 1991-1997 | 20 856 | 9257 (44.4) | 9.6 |
Framingham Heart Study | FHS | USA | 1991-1996 | 6710 | 289 (4.3) | 12 |
FINRISK Study | FINRISK | Finland | 2007 | 3822 | 172 (4.5) | 7.6 |
Health 2000 | Health 2000 | Finland | 2000 | 1946 | 138 (7.1) | 12.4 |
Health Professionals’ Follow-up Study | HPFS | USA | 1986 | 5587 | 939 (16.8) | 22 |
Inter99 study | Inter99 | Denmark | 1999 | 5607 | 279 (5.5) | 11 |
Malmö Diet and Cancer study | MDC-CC | USA | 1991-1994 | 3745 | 440 (11.9) | 16 |
Multi-Ethnic Study of Atherosclerosis | MESA | USA | 2000-2002 | 1535 | 136 (8.9) | 9.1 |
Nurses’ Health Study | NHS | USA | 1984 | 8832 | 1453 (17.1) | 28 |
Rotterdam Study I | RS-I | The Netherlands | 1989 | 2509 | 324 (12.9) | 10.2 |
Women's Genome Health Study | WGHS | USA | 1991 | 22 120 | 1855 (8.4) | 12 |
Total | 102 350 | 20 015 (19.6) | 12 |
Prospective nested case control.